Maria Cristina Leonardi, Maria Alessia Zerella, Matteo Lazzeroni, Nicola Fusco, Paolo Veronesi, Viviana Enrica Galimberti, Giovanni Corso, Samantha Dicuonzo, Damaris Patricia Rojas, Anna Morra, Marianna Alessandra Gerardi, Chiara Lorubbio, Mattia Zaffaroni, Maria Giulia Vincini, Roberto Orecchia, Barbara Alicja Jereczek-Fossa, Francesca Magnoni
Similar to invasive breast cancer, ductal carcinoma in situ is also going through a phase of changes not only from a technical but also a conceptual standpoint. From prescribing radiotherapy to everyone to personalized approaches, including radiotherapy omission, there is still a lack of a comprehensive framework to guide radiation oncologists in decision making. Many pieces of the puzzle are finding their place as high-quality data mature and are disseminated, but very often, the interpretation of risk factors and the perception of risk remain very highly subjective...
April 6, 2024: Healthcare (Basel, Switzerland)